Hepatocellular carcinoma (HCC) was the third leading cause of cancer-related death
globally in 2020. The treatment of the disease is complex, with a high possibility of disease …

Monitoring neurochemicals and imaging the molecular content of brain tissues in vitro, ex
vivo, and in vivo is essential for enhancing our understanding of neurochemistry and the …

The burgeoning demand for healthcare monitoring has brought field effect transistor (FET)
biosensors into the spotlight as a highly efficient detection technology. FET biosensors offer …

Biomarkers are primary indicators for precise diagnosis and treatment. The early
identification of health biomarkers has been sustained by the evolutionary success in sensor …

Promising advances in molecular medicine have promoted the urgent requirement for
reliable and sensitive diagnostic tools. Electronic biosensing devices based on field‐effect …

Cancer, a life-threatening genetic disease caused by abnormalities in normal cell growth
regulatory functions, poses a significant challenge that current medical technologies cannot …

Tremendous progress in nanotechnology and nanomedicine has made a significant positive
effect on cancer treatment by integrating multicomponents into a single multifunctional …

As information messengers for cell‐to‐cell communication, exosomes, typically small
membrane vesicles (30–150 nm), play an imperative role in the physiological and …

Detection of extracellular vesicles (EVs), particularly small EVs (sEVs), is of great
significance in exploring their physiological characteristics and clinical applications. The …

Ultrasensitive and population-scale cancer screening technologies are critical to reducing
cancer mortality. However, the current qRT-PCR falls short in high-throughput screening of …